Cargando…

Comparative amino acid decomposition analysis of potent type I p38α inhibitors

BACKGROUND AND PURPOSE OF THE STUDY: p38α is a member of mitogen-activated protein kinases (MAPK) considered as a prominent target in development of anti-inflammatory agents. Any abnormality in the phosphorylation process leads to the different human diseases such as cancer, diabetes and inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebadi, Ahmad, Razzaghi-Asl, Nima, Khoshneviszadeh, Mehdi, Miri, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680208/
https://www.ncbi.nlm.nih.gov/pubmed/23714278
http://dx.doi.org/10.1186/2008-2231-21-41
_version_ 1782273088591757312
author Ebadi, Ahmad
Razzaghi-Asl, Nima
Khoshneviszadeh, Mehdi
Miri, Ramin
author_facet Ebadi, Ahmad
Razzaghi-Asl, Nima
Khoshneviszadeh, Mehdi
Miri, Ramin
author_sort Ebadi, Ahmad
collection PubMed
description BACKGROUND AND PURPOSE OF THE STUDY: p38α is a member of mitogen-activated protein kinases (MAPK) considered as a prominent target in development of anti-inflammatory agents. Any abnormality in the phosphorylation process leads to the different human diseases such as cancer, diabetes and inflammatory diseases. Several small molecule p38α inhibitors have been developed up to now. In this regard, structural elucidation of p38 inhibitors needs to be done enabling us in rational lead development strategies. METHODS: Various interactions of three potent inhibitors with p38α active site have been evaluated in terms of binding energies and bond lengths via density function theory and MD simulations. RESULTS: Our comparative study showed that both ab initio and MD simulation led to the relatively similar results in pharmacophore discrimination of p38α inhibitors. CONCLUSION: The results of the present study may find their usefulness in pharmacophore based modification of p38α inhibitors.
format Online
Article
Text
id pubmed-3680208
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36802082013-06-13 Comparative amino acid decomposition analysis of potent type I p38α inhibitors Ebadi, Ahmad Razzaghi-Asl, Nima Khoshneviszadeh, Mehdi Miri, Ramin Daru Research Article BACKGROUND AND PURPOSE OF THE STUDY: p38α is a member of mitogen-activated protein kinases (MAPK) considered as a prominent target in development of anti-inflammatory agents. Any abnormality in the phosphorylation process leads to the different human diseases such as cancer, diabetes and inflammatory diseases. Several small molecule p38α inhibitors have been developed up to now. In this regard, structural elucidation of p38 inhibitors needs to be done enabling us in rational lead development strategies. METHODS: Various interactions of three potent inhibitors with p38α active site have been evaluated in terms of binding energies and bond lengths via density function theory and MD simulations. RESULTS: Our comparative study showed that both ab initio and MD simulation led to the relatively similar results in pharmacophore discrimination of p38α inhibitors. CONCLUSION: The results of the present study may find their usefulness in pharmacophore based modification of p38α inhibitors. BioMed Central 2013-05-29 /pmc/articles/PMC3680208/ /pubmed/23714278 http://dx.doi.org/10.1186/2008-2231-21-41 Text en Copyright © 2013 Ebadi et al.; licensee BioMed Central Ltd. http://www.creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://www.creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ebadi, Ahmad
Razzaghi-Asl, Nima
Khoshneviszadeh, Mehdi
Miri, Ramin
Comparative amino acid decomposition analysis of potent type I p38α inhibitors
title Comparative amino acid decomposition analysis of potent type I p38α inhibitors
title_full Comparative amino acid decomposition analysis of potent type I p38α inhibitors
title_fullStr Comparative amino acid decomposition analysis of potent type I p38α inhibitors
title_full_unstemmed Comparative amino acid decomposition analysis of potent type I p38α inhibitors
title_short Comparative amino acid decomposition analysis of potent type I p38α inhibitors
title_sort comparative amino acid decomposition analysis of potent type i p38α inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680208/
https://www.ncbi.nlm.nih.gov/pubmed/23714278
http://dx.doi.org/10.1186/2008-2231-21-41
work_keys_str_mv AT ebadiahmad comparativeaminoaciddecompositionanalysisofpotenttypeip38ainhibitors
AT razzaghiaslnima comparativeaminoaciddecompositionanalysisofpotenttypeip38ainhibitors
AT khoshneviszadehmehdi comparativeaminoaciddecompositionanalysisofpotenttypeip38ainhibitors
AT miriramin comparativeaminoaciddecompositionanalysisofpotenttypeip38ainhibitors